Login / Signup

CD56 expression predicts response to Daratumumab-based regimens.

Allen J RobinetteLaila HuricKameron DonaDon BensonFrancesca Cottini
Published in: Blood cancer journal (2024)
Keyphrases
  • poor prognosis
  • multiple myeloma
  • nk cells